OpenClinica Acquires BuildClinical

ST. LOUIS--(BUSINESS WIRE)--Thompson Street Capital Partners (TSCP), a private equity firm based in St. Louis, today announced the acquisition of BuildClinical, the leading patient recruitment solution for academic researchers, by OpenClinica, a provider of eClinical software solutions and a portfolio company of TSCP. Terms of the transaction were not disclosed.

The combination of OpenClinica and BuildClinical marks a significant milestone in the growth and expansion of both companies. Together, the two organizations will offer a complete set of solutions for recruitment, consent, enrollment, and data capture for clinical trial patients. BuildClinical’s leadership in the academic research recruitment space complements OpenClinica’s nearly two decades of supporting clinical trials at academic medical centers, while OpenClinica’s relationships with CROs, pharma sponsors, biotechs, and medical device customers will bring BuildClinical’s recruitment solutions to an even larger audience.

“OpenClinica is proud to align with the customer-oriented, entrepreneurial team at BuildClinical who have built a proven solution to accelerate clinical trial recruitment,” said Cal Collins, OpenClinica’s Co-Founder and CEO. “Together, OpenClinica and BuildClinical will enable clinical trials to get better data even faster with our integrated end-to-end technology solution.”

“The synergies between BuildClinical and OpenClinica are compelling for our clinical trial clients and our teams,” said Benji Hochberger, Founder & CEO at BuildClinical. “BuildClinical’s expertise in getting patients interested in and screened for participation in studies complements OpenClinica’s strengths in eligibility, consent, randomization, study conduct and data collection.”

“TSCP firmly believes in the critical role that academic researchers, and clinical researchers more broadly, play in enhancing human quality of life and introducing tomorrow’s life-saving treatments,” said Matt Scherrer, Managing Director at TSCP. “We’re excited to bring together two organizations that share this conviction, and we look forward to supporting them as they continue to grow.”

Edgemont Partners and Ice Miller served as financial and legal advisors, respectively, to BuildClinical, while Stout Capital and Bryan Cave Leighton Paisner served as financial and legal advisors, respectively, to OpenClinica.

About BuildClinical

BuildClinical is a health technology company that enables academic researchers to accelerate their clinical research patient recruitment efforts by engaging the exact population needed through digital advertising and ultimately reducing the patient access and awareness gaps that exist today.

About OpenClinica

OpenClinica accelerates clinical trials by automating data acquisition through its software-as-a-service platform. Offering a secure bridge between healthcare and research, OpenClinica is trusted by the world’s foremost life science companies, academic institutions, and government entities and has been used in more than 10,000 studies involving over five million patients. OpenClinica is proud to support hundreds of small, midsize and large research organizations spanning biotech, pharma, medical device manufacturing and contract research organizations.

About Thompson Street Capital Partners

Thompson Street Capital Partners (tscp.com) is a St. Louis-based private equity firm focused on investing in founder-owned middle market businesses in the life sciences and healthcare, software and technology, business and consumer services and products sectors. Founded in 2000, the firm has acquired more than 150 companies and had assets under management of over $4.8 billion as of March 31, 2024. TSCP partners with management teams to increase value by accelerating growth, both organically and via complementary acquisitions.